healthcare Archives - Page 2 of 2

Developments & Challenges within the Single Cell Analysis Ecosystem

May 17, 2022August 16, 2023 MarketsandMarkets Conferences

With just over a month till the MarketsandMarkets BioPharma Series kicks off in Boston on the 23rd & 24th of June 2022, we believed it would be apt to unveil a glimpse of the enriching insights our esteemed speakers shall be bringing to the tri-conference event. On the eve of our 3rd Annual MarketsandMarkets Single-Cell Analysis Conference, we sat down with Jun Wang, Associate Professor (Department of Biomedical Engineering) at Stony Brook University, New York who is also a keynote speaker at the conference. As part of the conversation, we…

BIOSIMILARS: Origins & The Path Forward

April 19, 2022August 16, 2023 MarketsandMarkets Conferences

Almost 7 years removed from the first FDA approved Biosimilar (Zarxio) in 2015, the US market for Biosimilars is projected to be highly beneficial over the next decade, for both pharmaceutical companies as well as patients, with RAND Corporation projecting estimated savings of over $54 Billion during this period. To truly comprehend such forecasts, a deeper understanding of what constitutes a ‘Biosimilar Drug’ is required. Essentially, the structure of a biosimilar is based on a pre-existing, approved drug known as a Biologic & possesses no significant clinical difference in safety,…

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

February 26, 2021 MarketsandMarkets Conferences

February 26th – MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT on the March 11, 2021 will hostindustry giants Fresenius Kabi, Charles River Laboratories, GenScript ProBio, Pall Corporation and MilliporeSigma to present their thoughts on the Top 10 Disruptions Through BioPharma Manufacturing in the next 5 year! MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Biocon Biologics, Ology Bioservices, Celonic AG, Gyroscope Therapeutics, GenIbet, Hemobras, H2i Group, MilliporeSigma, Orange Grove Bio, HORIBA, Porex Life Sciences Institute, Kaneka, Lonza, Cytiva, GEA North America, Batavia Biosciences, Nova…

Nicola Hodges from Royal United Hospitals Bath NHS Foundation, speaks about “Application of Point-Of-Care in disease outbreak”

February 10, 2021 MarketsandMarkets Conferences

Nicola is the POCT coordinator at the Royal United Hospitals Bath Foundation Trust and have been for just over 2 years now. She has been a senior biomedical scientist in biochemistry in the manual section again for around 2 years before this and a specialist BMS since 2003. Her most recent education was the certificate in expert practice in POCT awarded by the IBMS in 2021. She has always had a great passion for POCT, and she enjoys her job despite the many challenges. She believes that POCT is the…

Linda Krebs, & Allison Krebs-Bensch, of BeBe & Bella, LLC talk about V-Bella Homeopathic Boric Acid and Probiotic blend vaginal suppositories.

February 1, 2021 MarketsandMarkets Conferences

Linda and Allison have had a lifelong commitment to wellbeing and overall health. Living in the sunny South, they understand that proper skincare is an essential aspect of everyday life. In 2013 they became business partners creating the groundbreaking probiotic based skin care company – BeBe & Bella, LLC. Allison Krebs-Bensch, CEO of US Pharmaceutical Corporation, CEO and Co-Founder of BeBe & Bella, LLC followed her father in his original profession as a scientific innovator. As a trailblazer, Allison is always pushing to formulate products around new scientific discoveries. It…

Discussing ‘Reducing Errors at Point-Of-Care’ with Uchenna Okeahiala of Airedale and Bradford Hospitals Integrated Pathology Solutions, UK .

January 19, 2021 MarketsandMarkets Conferences

Graduated from University of Nigeria with a bachelor’s degree in Biomedical Sciences in 1989, Uchenna started her career as a Biomedical Scientist in Nigeria She relocated to the United Kingdom in 1991 where she obtained her Master’s degree in Biomedical Sciences from University of Cardiff with a Distinction in 1996 and went on to score a certificate in management from the Open University (1999). Later in 2006, she obtained a certificate in Extended Practice in Quality Management with Institute of Biomedical Sciences (IBMS). Since then has worked in various NHS…

Jyoti Chandok from Concordia University, Canada speaks about ‘Factors leading to the increase in demand POCT tech and challenges in upholding Quality Standards.’

January 14, 2021 MarketsandMarkets Conferences

Jyoti Chandok is a seasoned professional who has been working in the healthcare sector for over 19 years. She has fulfilled several roles specializing in patient care including phlebotomy, blood analysis for hematology, immunology, genetics, and specialized method development for HIV drug-level testing using mass spectrometry. Currently, Jyoti is an Assistant Chief Medical Technologist of Point-of-Care at the McGill University Health Center (MUHC) in Montreal, Quebec, Canada. She holds a B.Sc. in Cell and Molecular Biology from Concordia University and is an active member of both the Ordre professionnel des…

Technologies Transforming Real-World Evidence (RWE) Evidence in the Pharmaceutical Industry

September 5, 2019September 5, 2019 MarketsandMarkets Conferences

As new drugs are emerging every day, it is very important to ensure that the patients get right and effective treatment. One such step can be taken from Real World Evidence (RWE). In simple words, Real World Evidence means data and information collected outside of a clinical trial. This data can be electronic medical records, medical charts or other medical claims to assess patient outcomes. It is made sure that the patient’s identity is removed from the previous data to maintain the patient’s privacy. However, today’s real-world evidence data is…

Speaker Interview with Vanda Plecko for 4th Annual MarketsandMarkets Infection Control, Sterilization and Decontamination in Healthcare Congress

February 13, 2019February 13, 2019 MarketsandMarkets Conferences

London, UK February 11, 2019 – MarketsandMarkets recently interviewed Vanda Plecko, Consultant Microbiologist & Infection Control Doctor, NHS Highland regarding the 4th Annual MarketsandMarkets Infection control, Sterilization & Decontamination in Healthcare Congress, taking place on 28th February – 1st March 2019 in Hotel Novotel London West, UK. Vanda Plecko currently employed as Consultant Microbiologist and Infection Control Doctor in NHS Highland has published over 50 articles cited in international bases and more than 100 abstracts. Her interests are Infection Prevention in hospitals and community, molecular microbiological typing methods and antimicrobial…